SIMG
AZN icon

Sonora Investment Management Group’s AstraZeneca AZN Stock Holding History

Sonora Investment Management Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$367K Buy
2,391
+663
+38% +$100K 0.03% 204
2025
Q2 		$241K Buy
1,728
+293
+20% +$41.1K 0.02% 244
2025
Q1 		$211K Buy
+1,435
New +$208K 0.02% 263
2024
Q4 		– Sell
-1,398
Closed -$218K – 300
2024
Q3 		$218K Buy
+1,398
New +$226K 0.02% 261

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sonora Investment Management Group's AZN Position: Q3 2025 in Review

Sonora Investment Management Group increased its AstraZeneca (AZN) stake by 38% in Q3 2025, buying an estimated $100K and bringing the position to 2,391 shares worth $367K. The position accounts for 0.03% of the portfolio, ranked #204.

Sonora Investment Management Group first reported a position in AZN in Q3 2024 and has held it in 4 quarters since. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

  • Sonora Investment Management Group held 2,391 shares of AstraZeneca worth $367K as of Q3 2025.
  • Sonora Investment Management Group bought 663 AstraZeneca shares in Q3 2025, an estimated $100K.
  • AstraZeneca made up 0.03% of Sonora Investment Management Group's portfolio in Q3 2025, its #204 holding.
  • Sonora Investment Management Group first reported a position in AstraZeneca in Q3 2024 and has held it in 4 quarters since.
  • 1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Sonora Investment Management Group's 13F filing for Q3 2025, filed 7 Oct 2025.